| Daphne P Bazile, MD | |
|
439 Jennick Dr, Colonial Heights, VA 23834-4901 | |
| (804) 765-5206 | |
| (804) 765-5809 |
| Full Name | Daphne P Bazile |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 20 Years |
| Location | 439 Jennick Dr, Colonial Heights, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851558548 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0101259332 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southside Regional Medical Center | Petersburg, VA | Hospital |
| John Randolph Medical Center | Hopewell, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bon Secours Medical Group Richmond Specialty Care Llc | 8022440056 | 260 |
News Archive
Tripos®, a leading provider of drug discovery informatics products and services, today announced that Pfizer has become the latest customer of Benchware® Discovery 360 (D360). The novel license agreement allows Pfizer to deploy the capabilities of D360 to all scientists within its worldwide research sites.
Welcome to shopping during the coronavirus pandemic: customers clad in masks, slathered with sanitizer and surrounded by signage urging them to avoid close contact.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a Phase 1 clinical trial of MM-151, an oligoclonal therapeutic consisting of a mixture of three fully human monoclonal antibodies designed to bind to non-overlapping epitopes of the epidermal growth factor receptor.
CureDM, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application covering a Human proIslet Peptide (HIP) and methods related to its use and administration for treating type 1 diabetes.
› Verified 4 days ago
| Entity Name | Obhg Virginia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972807394 PECOS PAC ID: 9436323342 Enrollment ID: O20111110000430 |
News Archive
Tripos®, a leading provider of drug discovery informatics products and services, today announced that Pfizer has become the latest customer of Benchware® Discovery 360 (D360). The novel license agreement allows Pfizer to deploy the capabilities of D360 to all scientists within its worldwide research sites.
Welcome to shopping during the coronavirus pandemic: customers clad in masks, slathered with sanitizer and surrounded by signage urging them to avoid close contact.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a Phase 1 clinical trial of MM-151, an oligoclonal therapeutic consisting of a mixture of three fully human monoclonal antibodies designed to bind to non-overlapping epitopes of the epidermal growth factor receptor.
CureDM, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application covering a Human proIslet Peptide (HIP) and methods related to its use and administration for treating type 1 diabetes.
› Verified 4 days ago
| Entity Name | Bon Secours Medical Group Richmond Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477112225 PECOS PAC ID: 8022440056 Enrollment ID: O20191113002170 |
News Archive
Tripos®, a leading provider of drug discovery informatics products and services, today announced that Pfizer has become the latest customer of Benchware® Discovery 360 (D360). The novel license agreement allows Pfizer to deploy the capabilities of D360 to all scientists within its worldwide research sites.
Welcome to shopping during the coronavirus pandemic: customers clad in masks, slathered with sanitizer and surrounded by signage urging them to avoid close contact.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a Phase 1 clinical trial of MM-151, an oligoclonal therapeutic consisting of a mixture of three fully human monoclonal antibodies designed to bind to non-overlapping epitopes of the epidermal growth factor receptor.
CureDM, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application covering a Human proIslet Peptide (HIP) and methods related to its use and administration for treating type 1 diabetes.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daphne P Bazile, MD Po Box 639969, Cincinnati, OH 45263-9969 Ph: () - | Daphne P Bazile, MD 439 Jennick Dr, Colonial Heights, VA 23834-4901 Ph: (804) 765-5206 |
News Archive
Tripos®, a leading provider of drug discovery informatics products and services, today announced that Pfizer has become the latest customer of Benchware® Discovery 360 (D360). The novel license agreement allows Pfizer to deploy the capabilities of D360 to all scientists within its worldwide research sites.
Welcome to shopping during the coronavirus pandemic: customers clad in masks, slathered with sanitizer and surrounded by signage urging them to avoid close contact.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a Phase 1 clinical trial of MM-151, an oligoclonal therapeutic consisting of a mixture of three fully human monoclonal antibodies designed to bind to non-overlapping epitopes of the epidermal growth factor receptor.
CureDM, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application covering a Human proIslet Peptide (HIP) and methods related to its use and administration for treating type 1 diabetes.
› Verified 4 days ago
Dr. Tracey N Jones, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 439 Jennick Dr, Colonial Heights, VA 23834 Phone: 804-524-0890 Fax: 804-524-0897 | |
Dr. Keith M Roberts, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 439 Jennick Dr, Colonial Heights, VA 23834 Phone: 804-765-5206 Fax: 804-765-5809 | |
Dr. Edward Franklin Moschler Jr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 439 Jennick Dr, Colonial Heights, VA 23834 Phone: 804-765-5206 Fax: 804-765-5809 | |
Dr. Margaret Dahmus Walsh, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3660 Boulevard, Suite J, Colonial Heights, VA 23834 Phone: 804-520-1099 Fax: 804-520-8404 | |
Dr. William S Grizzard Jr., M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 439 Jennick Dr, Colonial Heights, VA 23834 Phone: 804-524-0890 Fax: 804-524-0897 | |
Dr. Charles W Smith Iii, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 439 Jennick Dr, Colonial Heights, VA 23834 Phone: 804-524-0890 Fax: 804-524-0897 |